Top-News

Penumbra Aktie News

Aktie
WKN:  A14Y65 ISIN:  US70975L1070 US-Symbol:  PEN Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
300,66 $
+5,94 $
+2,02%
258,21 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
9,33 Mrd. €
Streubesitz
1,43%
KGV
659,67
neu: Nachhaltigkeits-Score
42 %
Index-Zuordnung
-

Penumbra News

19.11.25 - PR Newswire
Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference
Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference PR Newswire
05.11.25 - PR Newswire
Penumbra, Inc. Reports Third Quarter 2025 Financial Results
Penumbra, Inc. Reports Third Quarter 2025 Financial Results PR Newswire
03.11.25 - PR Newswire
Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism
Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with ...
27.10.25 - PR Newswire
Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism
Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment ...
08.10.25 - PR Newswire
Penumbra, Inc. Schedules Investor Event at TCT Conference on October 26, 2025; Earnings Release and Conference Call for Third Quarter 2025 Scheduled for November 5, 2025
Penumbra, Inc. Schedules Investor Event at TCT Conference on October 26, 2025; Earnings Release and Conference Call for Third Quarter 2025 Scheduled for November 5, 2025 ...
09.09.25 - PR Newswire
New Survey Shows Management of Blood Clots is Inconsistent, Even for Patients with the Same Risk Profile
New Survey Shows Management of Blood Clots is Inconsistent, Even for Patients with the Same Risk Profile PR Newswire
27.08.25 - PR Newswire
Penumbra, Inc. Names Shruthi Narayan as Company President
Penumbra, Inc. Names Shruthi Narayan as Company President PR Newswire
20.08.25 - PR Newswire
Penumbra, Inc. to Present at Upcoming Investor Conferences
Penumbra, Inc. to Present at Upcoming Investor Conferences PR Newswire
30.07.25 - PR Newswire
Penumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference
Penumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference PR Newswire
29.07.25 - PR Newswire
Penumbra, Inc. Reports Second Quarter 2025 Financial Results
Penumbra, Inc. Reports Second Quarter 2025 Financial Results PR Newswire
01.07.25 - PR Newswire
Penumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025
Penumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025 PR Newswire
16.06.25 - PR Newswire
Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial
Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial PR Newswire
05.06.25 - PR Newswire
Penumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization
Penumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization PR Newswire
20.05.25 - PR Newswire
Penumbra, Inc. to Present at Upcoming Investor Conferences
Penumbra, Inc. to Present at Upcoming Investor Conferences PR Newswire
29.04.25 - PR Newswire
Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference
Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference PR Newswire
23.04.25 - PR Newswire
Penumbra, Inc. Reports First Quarter 2025 Financial Results
Penumbra, Inc. Reports First Quarter 2025 Financial Results PR Newswire
08.04.25 - PR Newswire
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Penumbra, Inc. (NYSE: PEN)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Penumbra, Inc. (NYSE: PEN) PR Newswire
03.04.25 - PR Newswire
Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025
Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025 PR Newswire
02.04.25 - PR Newswire
Seven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
Seven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and ...
21.02.25 - PR Newswire
Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors
Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors PR Newswire

Newssuche

Videos

newspaper
05.12.25 +1,73%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »